BROMOCRIPTINE TABLETS 2.5mg "TOWA" (ブロモクリプチン錠2.5mg「トーワ」)

País: Japão

Língua: inglês

Origem: すりの適正使用協議会 RAD-AR Council, Japan

Ingredientes ativos:

Bromocriptine mesilate

Disponível em:

TOWA PHARMACEUTICAL CO., LTD.

DCI (Denominação Comum Internacional):

Bromocriptine mesilate

Forma farmacêutica:

white to faintly yellowish or faintly brownish white tablet with a split line, diameter: 7.0 mm, thickness: 2.7 mm

Resumo do produto:

Print on wrapping: ブロモクリプチン2.5mg「トーワ」, Bromocriptine 2.5, ブロモクリプチン, 2.5mg, Tw.DR

Folheto informativo - Bula

Drug Information Sheet("Kusuri-no-Shiori")
Internal
Published: 06/2017
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
BROMOCRIPTINE TABLETS 2.5MG "TOWA"
ACTIVE INGREDIENT:
Bromocriptine mesilate
DOSAGE FORM:
white to faintly yellowish or faintly brownish white tablet
with a split line, diameter: 7.0 mm, thickness: 2.7 mm
IMPRINT OR PRINT ON WRAPPING:
ブロモクリプチン 2.5mg「トーワ」,
Bromocriptine 2.5, ブロモクリプチン, 2.5mg, Tw.DR
EFFECTS OF THIS MEDICINE
This medicine suppresses excess secretion of prolactin or growth
hormone by stimulating
dopamine receptors in the pituitary gland in the brain. It
consequently controls milk secretion,
eliminates the cause of infertility, and improves symptoms of
acromegaly. It also improves
symptoms of Parkinson's syndrome by stimulating dopamine receptors in
the brain striatum.
It is usually used to treat galactorrhea, hyperprolactinemic ovulatory
disturbances,
acromegaly, pituitary gigantism and Parkinson's syndrome.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
If you are a patient with pregnancy-induced hypertension syndrome,
puerperal hypertension
(6 to 8 weeks after delivery), cardiac valve lesion or its history.
・If you are pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may
interact to enhance or
diminish medicinal effects. Beware of over-the-counter medicines and
dietary supplements
as well as other prescription medicines.)
DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE)
�